• VX-661: Practical F508del CFTR Rescue Workflows

  2026-08-28

  Learn how to use VX-661 to separate CFTR trafficking rescue from channel activation in cell-based cystic fibrosis research. This workflow-focused guide covers dosing, orthogonal readouts, combination timing, calnexin-aware assay design, and troubleshooting.

• Thermal-Protective Hydrogel for Curative Tumor Ablation

  2026-08-28

  The reference study introduces an injectable MR@CaP@HA hydrogel that combines local thermal insulation with pH- and glutathione-responsive delivery of mitoxantrone and Resiquimod (R-848) during radiofrequency ablation. By protecting adjacent tissue while strengthening immunogenic cell death, dendritic-cell maturation, and macrophage polarization, the platform improved residual-tumor control and achieved complete tumor eradication in a subset of treated animals.

• Partial BACE Inhibition Preserves Synaptic Transmission

  2026-08-27

  Satir et al. show that moderate β-secretase inhibition can lower amyloid β production without disrupting synaptic transmission in cultured cortical neurons. The study supports dose-titrated BACE inhibition as a mechanistically informed strategy for reducing amyloidogenic processing while limiting functional effects on neuronal signaling.

• Fluorescein TSA Fluorescence System Kit Workflow

  2026-08-27

  The Fluorescein TSA Fluorescence System Kit converts weak HRP-linked signals into dense, spatially localized fluorescein deposits for IHC, ICC, and ISH. This practical guide shows how to adapt the workflow for low-abundance targets, regional brain biology, multiplex experiments, and common fluorescence troubleshooting challenges.

• SU 5402 Workflows for RTK Signaling Research

  2026-08-26

  SU 5402 provides a practical way to perturb VEGFR2, FGFR1, and PDGFRβ signaling in cancer biology, including multiple myeloma research. Its use in human iPSC-derived sensory neurons is an exploratory extension that can connect receptor signaling, neuronal health, and HSV-1 reactivation assays without treating the model as already validated for this inhibitor.

• Triamcinolone Protocol for Glucocorticoid Studies

  2026-08-26

  Triamcinolone (SKU B1859) provides a defined synthetic glucocorticoid agonist for controlled studies of glucocorticoid signaling, inflammation, and immunosuppression. This guidance focuses on solvent selection, stock handling, controls, and storage; the compound is for scientific research only and should not be used for diagnostic, therapeutic, or clinical purposes.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide

  2026-08-25

  Cy3 Rabbit Anti-Goat IgG (H+L) Antibody is a Cy3-conjugated secondary antibody for detecting goat IgG in ICC/IF, IHC, flow cytometry, and ELISA workflows. It should not be used as a primary antibody, for direct antigen detection, or with non-goat primary antibodies without separate validation.

• CCK-8, Endogenous Opioids, and Withdrawal Anxiety

  2026-08-25

  Wen and colleagues showed that centrally administered CCK-8 reduces anxiety-like behavior during morphine withdrawal in rats through CCK1 receptor signaling and endogenous μ-opioid involvement. The study separates withdrawal-related negative affect from reward-associated behavior and provides a pharmacological framework for opioid addiction and withdrawal studies.

• Patient-Derived Gastric Cancer Assembloids

  2026-08-24

  Shapira-Netanelov and colleagues developed a gastric cancer assembloid system that combines patient-matched tumor organoids with multiple stromal cell subpopulations derived from the same tumor tissue. The model reproduced important tumor–stroma effects on gene expression and drug sensitivity, supporting more physiologically relevant studies of resistance mechanisms and personalized treatment strategies.

• PR-619: Cell-Based DUB Inhibition Workflows

  2026-08-24

  PR-619 is a cell-permeable, reversible deubiquitylating enzymes inhibitor for accumulating ubiquitinated proteins without directly blocking proteasomal catalysis. This guide translates its broad DUB activity into practical workflows for ubiquitination pathway research, autophagy assays, cancer biology, and neurodegeneration studies.

• Verapamil in Hypoxia-Driven Urothelial Inflammation

  2026-08-23

  Verapamil ((±)-Verapamil) helps separate hypoxic stress from prolonged ROS/TXNIP/NLRP3-associated inflammation in urothelial cell assays. This workflow combines duration-resolved hypoxia, orthogonal readouts, and mechanism-aware controls to improve interpretation and troubleshooting.

• Firefly Luciferase mRNA as a Delivery Readout

  2026-08-22

  Firefly Luciferase mRNA (ARCA, 5-moUTP) is more than a bright reporter: it can expose how mRNA chemistry, delivery, and cell state shape experimental outcomes. This guide connects assay design with evidence from a lyophilized nanoparticle study to support more interpretable research decisions.

• Coronavirus Macrodomains and PARP Antiviral Defense

  2026-08-21

  Grunewald et al. show that coronavirus macrodomains counter host PARP-dependent restriction and interferon induction, with PARP12 and PARP14 emerging as important contributors. The study combines pharmacological inhibition, targeted knockdown, primary macrophage infection, and mouse and human cell experiments to connect ADP-ribosylation biology with coronavirus replication and innate immunity.

• Pregnenolone Carbonitrile: PXR Workflow Guide

  2026-08-20

  Pregnenolone Carbonitrile enables controlled rodent PXR activation for cytochrome P450 CYP3A induction, hepatic detoxification studies, and cholestatic liver-injury models. Its value extends beyond metabolic profiling to assays of pyroptosis, liver fibrosis, and hepatic stellate cell trans-differentiation inhibition.

• SB525334 for TGF-beta1 Pathway Research

  2026-08-20

  Use SB525334 as a selective ALK5 perturbation tool to connect TGF-beta signaling with Smad2/3 activity, profibrotic gene expression, and tissue-repair phenotypes. This workflow translates findings from diabetic foot ulcer research into controlled cell, ex vivo, and renal fibrosis model experiments while keeping pathway inhibition distinct from simple TGF-β1 measurement.

8538 records 1/570 page Next 12345 下5页 Last page